Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, EBITDA Accretion and Cashflow GenerationDUBLIN, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a ...
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic ...
DUBLIN, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
(MENAFN- GlobeNewsWire - Nasdaq) DUBLIN, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes ...
Trinity Biotech (TRIB) has received World Health Organization approval for the offshored and outsourced upstream manufacturing activities of its ...
Trinity Biotech (TRIB) announced a strategic collaboration with a leading bioinformatics company to conduct advanced analysis on clinical trial ...
A well-recognized pharmaceutical industry executive, Mr. Evangelista brings over 30 years of strategic leadership and operational expertise to Trinity, having previously served in consulting, CRO, and ...
In accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, The Biotech Growth Trust PLC (the "Company") announces the following: As at 31 October 2025, the ...
Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 17 July 2025 to make market purchases of the Company's own shares up to an aggregate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback